Publications | Department of Population Medicine

Patients deserve better information on new drugs. (Pubmed Abstract)

Authors

Davis C, Wagner AK, Mintzes B, Scowcroft H, Woloshin S, Naci H

Abbreviation

BMJ

Volume

387

Publication Date

2024-10-29

Financial toxicity of withdrawn poly (ADP-ribose) polymerase inhibitor indications for ovarian cancer. (Pubmed Abstract)

Authors

Dottino JA, Esselen KM, Costa R, Argetsinger S, Shahzad M, Ross-Degnan D, Wagner AK

Abbreviation

Value Health

Publication Date

2024-06-11

Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway. (Pubmed Abstract)

Authors

Shahzad M, Naci H, Esselen KM, Dottino JA, Wagner AK

Abbreviation

J Pharm Policy Pract

Volume

Issue

Publication Date

2024-06-04

Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis. (Pubmed Abstract)

Authors

Naci H, Zhang Y, Woloshin S, Guan X, Xu Z, Wagner AK

Abbreviation

Lancet Oncol

Publication Date

2024-05-13

Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020. (Pubmed Abstract)

Authors

Wei Y, Zhang Y, Xu Z, Wang G, Zhou Y, Li H, Shi L, Naci H, Wagner AK, Guan X

Abbreviation

Lancet Reg Health West Pac

Volume

Publication Date

2024-04-02

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021. (Pubmed Abstract)

Authors

Zhou Y, Naci H, Chen D, Bai L, Shi L, Guan X, Wagner AK

Abbreviation

BMJ Glob Health

Volume

Issue

Publication Date

2023-10-01

Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021. (Pubmed Abstract)

Authors

McClean AR, Wagner AK, Lu CY

Abbreviation

JCO Oncol Pract

Publication Date

2023-08-28

The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data. (Pubmed Abstract)

Authors

Yang Y, Zhang Y, Wagner AK, Li H, Shi L, Guan X

Abbreviation

J Glob Health

Volume

Publication Date

2023-08-11

Impact of a national antibiotic stewardship intervention in China targeting carbapenem overuse: an interrupted time-series analysis. (Pubmed Abstract)

Authors

Xu S, Kitchen C, Liu Y, Kabba JA, Hayat K, Wang X, Wang G, Zhang F, Chang J, Fang Y, Wagner AK, Ross-Degnan D

Abbreviation

Int J Antimicrob Agents

Publication Date

2023-07-28

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis. (Pubmed Abstract)

Authors

Ivama-Brummell AM, Marciniuk FL, Wagner AK, Osorio-de-Castro CGS, Vogler S, Mossialos E, Tavares-de-Andrade CL, Naci H

Abbreviation

Lancet Reg Health Am

Volume

Publication Date

2023-05-17

Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe. (Pubmed Abstract)

Authors

Davis C, Wagner AK, Salcher-Konrad M, Scowcroft H, Mintzes B, Pokorny AMJ, Lew J, Naci H

Abbreviation

BMJ

Volume

380

Publication Date

2023-03-29

The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis. (Pubmed Abstract)

Authors

Husin M, Teh XR, Ong SM, Lim YMF, Ang SH, Chan CL, Lim MT, Shanmugam S, Khamis N, Jaafar FSA, Ibrahim NI, Nasir NH, Kusuma D, Wagner AK, Ross-Degnan D, Atun R, Sivasampu S

Abbreviation

Prim Care Diabetes

Publication Date

2023-03-15

Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway. (Pubmed Abstract)

Authors

Shahzad M, Naci H, Wagner AK

Abbreviation

JAMA

Publication Date

2023-01-27

Newly approved cancer drugs in China - innovation and clinical benefit. (Pubmed Abstract)

Authors

Zhang Y, Wagner AK, Guan X

Abbreviation

Nat Rev Clin Oncol

Publication Date

2023-01-16

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020 (View Abstract)

Publication Date

2022-08-10

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020. (Pubmed Abstract)

Authors

Zhang Y, Naci H, Wagner AK, Xu Z, Yang Y, Zhu J, Ji J, Shi L, Guan X

Abbreviation

JAMA Netw Open

Volume

Issue

Publication Date

2022-08-01

New-onset cancer cases in FDA's Sentinel System: a large distributed system of US electronic healthcare data. (Pubmed Abstract)

Authors

Haug NR, Wagner AK, McGlynn KA, Leonard CE, Nguyen MD, Major JM

Abbreviation

Cancer Epidemiol Biomarkers Prev

Publication Date

2022-07-15

Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil. (Pubmed Abstract)

Authors

Ivama-Brummell AM, Wagner AK, Pepe VLE, Naci H

Abbreviation

BMJ Glob Health

Volume

Issue

Publication Date

2022-03-22

Use of Palliative Care Among Commercially Insured Patients With Metastatic Cancer Between 2001 and 2016. (Pubmed Abstract)

Authors

Ferrario A, Zhang F, Ross-Degnan D, Wharam JF, Twaddle ML, Wagner AK

Abbreviation

JCO Oncol Pract

Publication Date

2022-01-05

Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated Approval (Pubmed Abstract) (View Abstract)

Authors

Shahzad M, Naci H, Wagner AK.

Volume

181

Issue

Publication Date

2021-10-18

Real-world Use of and Spending on New Oral Targeted Cancer Drugs in the US, 2011-2018 (Pubmed Abstract)

Authors

Fu M, Naci H, Booth CM, Gyawali B, Cosgrove A, Toh S, Xu Z, Guan X, Ross-Degnan D, Wagner AK

Publication Date

2021-10-18

Childhood Cancer Drugs in China: An Overview and Comparison of Regulatory Approvals in China and the United States. (Pubmed Abstract)

Authors

Zhang Y, Wagner AK, Du H, Han T, Gupta S, Denburg AE, Frazier AL, Guan X, Shi L

Abbreviation

Int J Cancer

Publication Date

2021-09-18

Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs. (Pubmed Abstract)

Authors

Naci H, Guan X, Woloshin S, Xu Z, Wagner AK

Abbreviation

JAMA Intern Med

Publication Date

2021-07-12

Forecasting essential childhood cancer drug need: An innovative model-based approach. (Pubmed Abstract)

Authors

Hughes TM, Empringham B, Wagner AK, Ward ZJ, Yeh J, Gupta S, Frazier AL, Denburg AE

Abbreviation

Cancer

Publication Date

2021-04-12

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending. (Pubmed Abstract)

Authors

Huang T, Wagner AK, Bai L, Huang C, Guan X, Shi L

Abbreviation

Cancer Commun (Lond)

Publication Date

2021-02-20

Efficacy and costs of spinal muscular atrophy drugs (Pubmed Abstract)

Authors

Darrow JJ, Sharma M, Shroff M, Wagner AK

Abbreviation

Sci Transl Med

Volume

Issue

569

Publication Date

2020-11-11

Intensity of End-of-Life Care in a Cohort of Commercially Insured Women With Metastatic Breast Cancer in the United States. (Pubmed Abstract)

Authors

Ferrario A, Xu X, Zhang F, Ross-Degnan D, Wharam JF, Wagner AK

Abbreviation

JCO Oncol Pract

Publication Date

2020-11-10

What are the volume and budget needs to provide chemotherapy to all children with acute lymphoblastic leukaemia in Thailand? Development and application of an estimation tool (Pubmed Abstract)

Authors

Sruamsiri R, Ferrario A, Ross-Degnan D, Denburg AE, Frazier AL, Gupta S, Ward ZJ, Yeh JM, Wagner AK

Abbreviation

BMJ Open

Volume

Issue

Publication Date

2020-10-26

The Complex Cancer Care Coverage Environment - What is the Role of Legislation? A Case Study from Massachusetts. (Pubmed Abstract)

Authors

Leopold C, Haffajee RL, Lu CY, Wagner AK

Abbreviation

J Law Med Ethics

Volume

Issue

Publication Date

2020-10-08

Article 3: 1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities. (Pubmed Abstract)

Authors

Trap B, Sembatya MN, Imi M, Seru M, Wagner AK, Ross-Degnan D

Abbreviation

J Pharm Policy Pract

Volume

Publication Date

2020-09-01

Sales of anti-cancer medicines; China, Indonesia, Kazakhstan, Malaysia, Philippines and Thailand (View Abstract)

Authors

Ferrario A, Stephens P, Guan X, Ross-Degnan D, Wagner A

Abbreviation

Bull World Health Organ

Volume

Publication Date

2020-07-01

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand. (Pubmed Abstract)

Authors

Leopold C, Lu CY, Wagner AK

Abbreviation

BMC Health Serv Res

Volume

Issue

Publication Date

2020-04-25

Differences in reimbursement listing of anticancer therapies in China: an observational study. (Pubmed Abstract)

Authors

Guan X, Zhang Y, Wushouer H, Shi L, Ross-Degnan D, Wagner AK

Abbreviation

BMJ Open

Volume

Issue

Publication Date

2020-01-06

Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database (Pubmed Abstract) (View Abstract)

Authors

Zhang J, Ung COL, Wagner AK, Guan X, Shi L

Abbreviation

Clinical Epidemiology

Volume

2019

Issue

Publication Date

2019-12-10

Costs and effectiveness of the supervision, performance assessment and recognition (SPARS) strategy for medicines management in Uganda. (Pubmed Abstract)

Authors

Kwesiga B, Wagner AK, Seru M, Ross-Degnan D, Trap B

Abbreviation

J Pharm Policy Pract

Volume

Publication Date

2019-12-03

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study. (Pubmed Abstract)

Authors

Guan X, Wushouer H, Yang M, Han S, Shi L, Ross-Degnan D, Wagner AK

Abbreviation

BMJ Open

Volume

Issue

Publication Date

2019-11-28

The Brazilian private pharmaceutical market after the first ten years of the generics law. (Pubmed Abstract)

Authors

Bertoldi AD, Wagner AK, Emmerick ICM, Chaves LA, Stephens P, Ross-Degnan D

Abbreviation

J Pharm Policy Pract

Volume

Publication Date

2019-08-14

Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program. (Pubmed Abstract)

Authors

Leopold C, Araujo-Lane C, Rosenberg C, Gilkey M, Wagner AK

Abbreviation

Pharmacoecon Open

Publication Date

2019-07-19

A new analytic tool developed to assess safe use recommendations. (Pubmed Abstract)

Authors

Cocoros NM, Wagner A, Haynes K, Petrone AB, Fazio-Eynullayeva E, Ding Y, Izem R, Lee JY, Major JM, Nguyen M, Ju J

Abbreviation

Pharmacoepidemiol Drug Saf

Publication Date

2019-02-12

Pharmaceutical system strengthening in Uganda: implementing a holistic, evidence-informed, long-term strategy. (Pubmed Abstract)

Authors

Oteba M, Wagner AK, Seru M, Embrey M, Trap B

Abbreviation

J Pharm Policy Pract

Volume

Publication Date

2018-10-15

Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans (View Abstract)

Authors

Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L Ross-Degnan D, Wharam JF

Abbreviation

Breast Cancer Res Treat

Volume

171

Issue

Publication Date

2018-09-01

Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic Drugs. (Pubmed Abstract)

Authors

Gagne JJ, Popovic JR, Nguyen M, Sandhu SK, Greene P, Izem R, Jiang W, Wang Z, Zhao Y, Petrone AB, Wagner AK, Dutcher SK

Abbreviation

Drug Saf

Publication Date

2018-08-17

An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries. (Pubmed Abstract)

Authors

Morgan SG, Good CB, Leopold C, Kaltenboeck A, Bach PB, Wagner A

Abbreviation

Health Policy

Publication Date

2018-07-21

Quality Reporting by Payers: A Mixed-Methods Study of Provider Perspectives and Practices. (Pubmed Abstract)

Authors

Garabedian LF, Sinaiko AD, Ross-Degnan D, Abu-Jaber T, Hoefer M, Oddleifson S, Wagner AK

Abbreviation

Qual Manag Health Care

Volume

Issue

Publication Date

2018-06-29

State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015 (View Abstract)

Authors

Lu CY, Zhang F, Golonski N, Lupton C, Jeffrey P, Wagner AK

Abbreviation

Value Health

Volume

Issue

Publication Date

2018-06-01

Total and out-of-pocket expenditures among women with metastatic breast cancer in low-deductible versus high-deductible health plans. (Pubmed Abstract)

Authors

Leopold C, Wagner AK, Zhang F, Lu CY, Earle CC, Nekhlyudov L, Ross-Degnan D, Wharam JF

Abbreviation

Breast Cancer Res. Treat.

Publication Date

2018-06-01

Defining Value of Cancer Therapeutics-A Health System Perspective. (Pubmed Abstract)

Authors

Leopold C, Peppercorn JM, Zafar SY, Wagner AK

Abbreviation

J. Natl. Cancer Inst.

Publication Date

2018-05-18

Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer. (Pubmed Abstract)

Authors

Lu CY, Zhang F, Wagner AK, Nekhlyudov L, Earle CC, Callahan M, LeCates R, Xu X, Ross-Degnan D, Wharam JF

Abbreviation

Breast Cancer Res. Treat.

Publication Date

2018-05-12

Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment. (Pubmed Abstract)

Authors

Wharam JF, Zhang F, Lu CY, Wagner AK, Nekhlyudov L, Earle CC, Soumerai SB, Ross-Degnan D

Abbreviation

J. Clin. Oncol.

Publication Date

2018-02-28

State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015. (Pubmed Abstract)

Authors

Lu CY, Zhang F, Golonski N, Lupton C, Jeffrey P, Wagner AK

Abbreviation

Value Health

Volume

Issue

Publication Date

2017-11-07